recent post

Bio-Absorbable Screws: Transforming Orthopaedic Care with Cutting-Edge Innovation

December 10, 2024
recent post

Union Health Minister Nadda launches 100-day intensified nationwide campaign to reduce TB incidence

recent post

Metropolis Healthcare acquires 100% stake in Core Diagnostics for Rs 246 cr

December 9, 2024
recent post

BPCL with Smile Train supports underserved communities in Sagar district, MP

recent post

Aster CMI Hospital, Govt of Arunachal Pradesh MoU to provide liver transplantation services

Zini.ai raises Pre Series A funding from London-based Solarus Group

Zini.ai raises Pre Series A funding from London-based Solarus Group

The funds will be used towards upgrading Zini’s technological abilities, business development and expanding into new markets Zini.ai, an AI-powered multilingual virtual physician, a flagship product by Delhi-based Grainpad, has raised Pre Series A funding from Solarus Group, a London-based Venture Capital & Private Equity firm with a presence in England, Egypt and India. The funds will be used towards enhancing existing technology, new business development and expanding into new geographies.  Zini.ai is India’s first AI-powered, voice-based virtual physician designed by a team of experienced doctors and techies. Accessible through an app, Zini allows users to ‘Talk to Zini’ about any medical symptom or health issues. With an Alexa-like experience, the app can evaluate 950+ health symptoms, 300+ diseases, provide a detailed report, recommend the best course of action and share details of nearby medical facilities that a patient can reach out to. Commenting on the fundraise, Dr Rohit Sharma, CEO and Founder, Zini.ai, said, “We started Zini to make expert medical advice accessible to everyone and to bridge the gap in the doctor-patient ratio in India. Over the last three years, our conversational AI-powered multilingual virtual physician ‘Zini’ has received an overwhelming response from hospitals, our customers and the medical fraternity. We are pleased with the further validation of our product and business model from our investors. The new investment will accelerate our next phase of growth and enable us to strengthen our existing technology.” Tamer Soliman, CEO and Director, Solarus Group, said “We are excited to be investing in Zini.ai. The team has shown great commitment over the last several years in building a product that is solving a real-world problem. Zini’s ability to discuss symptoms, diagnose accurately and recommend the best course of action has the potential to help every player involved in the healthcare sector, from patients to healthcare professionals. We believe that the startup is solving a large unmet need in the market and it has the potential to become a defining brand in the category it operates in. We are happy to be a part of their growth story.”  A virtual physician like Zini can address the gap in the doctor-patient ratio in India. Furthermore, Zini can also help gather structured data, which can promote research and help policymakers make data-driven decisions about their communities. Available on Android, a user can download the app and start using Zini as their health guide. With ‘open conversational abilities’, Zini allows users to 'talk to ZINI’ in natural language or as a free text-based chat. Each user gets a Unique Global Health ID where all the relevant information about the patient gets recorded. Zini currently works with five hospitals, 10+ Telehealth platforms, and has 15,000+ Android users, thus validating its use case in an array of market segments.